Similarly, in liver cancer, FGL1 expression decreases with disease progression, and compared with wild-type mice, the growth rate of liver cancer in FGL1-knockout mice is faster, possibly involving the AKT and mTOR pathways [41]. Here, AKT1 is linked to liver cancer.